CD4 and neoplasm: For this, we transferred Marilyn CD4 T cells into tumor-bearing RAG.KO mice, which has no endogenous CD8 T cells, and found that 50% of the mice rejected the tumor and all of them had a survival advantage respect to untreated mice (Fig. 1C; ref. 1).